Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Exalter has extended the collection of applications until March 27th

2/19/25 OTCI

Artgen Biotech will not place an additional share issue

2/19/25 ABIO

Chizhik relaunched a distribution center in Novosibirsk

2/19/25 FIVE

AllInstruments.ru fulfills the plan for 2024

2/19/25 VSEH

The EU will ban the import of primary aluminum from Russia

2/19/25 RUAL

Board of Directors of M.Video-Eldorado appointed Felix Lib as the company's general director

2/19/25 MVID

Delimobil increased the share of fleet maintenance at its own service stations

2/19/25 DELI

General Director of M.Video-Eldorado may become Felix Lieb

2/19/25 MVID

Oil pumping from Kazakhstan through the CPC decreased by 30%

2/18/25 TRNFP

Moscow Exchange launched the full version of the Algopack service

2/18/25 MOEX